A Gelatin Methacrylate-Based Hydrogel as a Potential Bioink for 3D Bioprinting and Neuronal Differentiation.
Elisa Marozzi CruzLucas Simões MachadoLaura Nicoleti ZamproniLarissa Valdemarin BimPaula Scanavez FerreiraLeonardo Alves PintoLuiz Antonio PessanEduardo Henrique BackesMarimelia Aparecida PorcionattoPublished in: Pharmaceutics (2023)
Neuronal loss is the ultimate pathophysiologic event in central nervous system (CNS) diseases and replacing these neurons is one of the most significant challenges in regenerative medicine. Providing a suitable microenvironment for new neuron engraftment, proliferation, and synapse formation is a primary goal for 3D bioprinting. Among the various biomaterials, gelatin methacrylate (GelMA) stands out due to its Arg-Gly-Asp (RGD) domains, which assure its biocompatibility and degradation under physiological conditions. This work aimed to produce different GelMA-based bioink compositions, verify their mechanical and biological properties, and evaluate their ability to support neurogenesis. We evaluated four different GelMA-based bioink compositions; however, when it came to their biological properties, incorporating extracellular matrix components, such as Geltrex TM , was essential to ensure human neuroprogenitor cell viability. Finally, Geltrex TM : 8% GelMA (1:1) bioink efficiently maintained human neuroprogenitor cell stemness and supported neuronal differentiation. Interestingly, this bioink composition provides a suitable environment for murine astrocytes to de-differentiate into neural stem cells and give rise to MAP2-positive cells.
Keyphrases
- extracellular matrix
- neural stem cells
- tissue engineering
- endothelial cells
- stem cells
- cerebral ischemia
- hyaluronic acid
- induced apoptosis
- induced pluripotent stem cells
- pluripotent stem cells
- drug delivery
- blood brain barrier
- bone regeneration
- spinal cord
- cell cycle arrest
- oxidative stress
- mesenchymal stem cells
- wound healing